Arcturus Therapeutics Holdings Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARCT Nasdaq 2836 arcturusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcturus Therapeutics Holdings Inc.

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation - Sep 28th, 2026 7:57 am
Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platform - Sep 24th, 2026 9:02 pm
CoreWeave upgraded, Etsy downgraded: Wall Street's top analyst calls - Sep 24th, 2026 7:41 am
Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform - Sep 23rd, 2026 2:01 pm
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform - Sep 18th, 2026 7:00 am
Arcturus Therapeutics to Participate in Upcoming Investor Conferences - Aug 31st, 2026 2:01 pm
Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy? - Aug 27th, 2026 7:55 am
Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players - Aug 21st, 2026 12:54 pm
Moderna And Merck's Cancer Vaccine: Are Investors Putting The Cart Before The Horse? - Aug 20th, 2026 2:07 pm
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline - Aug 11th, 2026 7:04 pm
Arcturus Therapeutics Q2 Earnings Call Highlights - Aug 6th, 2026 4:04 pm
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates - Aug 6th, 2026 3:20 pm
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress - Aug 6th, 2026 2:01 pm
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 - Jul 28th, 2026 2:01 pm
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference - Jul 20th, 2026 2:01 pm
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar? - Jul 3rd, 2026 5:06 am
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis - Jul 2nd, 2026 5:00 am
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies - Jun 5th, 2026 3:02 am